Literature DB >> 8833328

Tetracycline-controlled gene expression system achieves high-level and quantitative control of gene expression.

D X Yin1, L Zhu, R T Schimke.   

Abstract

The tetracycline-controlled gene expression system utilizes the control elements of the tetracycline resistance operon encoded in TnlO of Escherichia coli to control gene expression in eukaryotic cells. Here we demonstrate the quantitative control of the expression of the luciferase gene, dihydrofolate reductase gene, and bcl-2 gene in HeLa S3 or Chinese hamster ovary AA8 cells using the tetracycline-controlled gene expression system. Regardless of the host cell lines or the genes being expressed, there is a common range of tetracycline concentration within which the expression of genes is most sensitively regulated. In addition, the maximal gene expression level of the tetracycline-controlled gene expression system is higher than that of the wild-type CMV promoter/enhancer-driven system. Nonetheless, careful selection of stably transfected clones is necessary to achieve the optimally regulated gene expression using this system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833328     DOI: 10.1006/abio.1996.0112

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  19 in total

1.  A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR).

Authors:  P Honkakoski; I Jääskeläinen; M Kortelahti; A Urtti
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

2.  Regulatable killing of eukaryotic cells by the prokaryotic proteins Kid and Kis.

Authors:  Guillermo de la Cueva-Méndez; Anthony D Mills; Lorena Clay-Farrace; Ramón Díaz-Orejas; Ronald A Laskey
Journal:  EMBO J       Date:  2003-01-15       Impact factor: 11.598

3.  Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells.

Authors:  C Shen; A Buck; G Mehrke; B Polat; H Gross; M Bachem; S Reske
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

4.  A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells.

Authors:  Frank Stegmeier; Guang Hu; Richard J Rickles; Gregory J Hannon; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

5.  Construction of Xenopus (B3.2) and human (HeLa) cell lines expressing the tetracycline-controlled transactivator (tTA)

Authors:  O Camacho-Vanegas; L Mannucci; F Amaldi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

6.  Cell-type specificity of short-range transcriptional repressors.

Authors:  J R Ryu; L K Olson; D N Arnosti
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

7.  Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activities.

Authors:  Rainer Loew; Elisa Vigna; Dirk Lindemann; Luigi Naldini; Herman Bujard
Journal:  J Mol Genet Med       Date:  2006-07-17

8.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

Authors:  A Kistner; M Gossen; F Zimmermann; J Jerecic; C Ullmer; H Lübbert; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Establishment of stable melanoma cell line expressing a novel gene, jpk, using a tetracycline-controlled gene expression system.

Authors:  Byung-Gyu Kim; Meang Sub Cheng; Hyoung Woo Park; Myoung Hee Kim
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

10.  Tetracycline-inducible packaging cell line for production of flavivirus replicon particles.

Authors:  Tracey J Harvey; Wen Jun Liu; Xiang Ju Wang; Richard Linedale; Michael Jacobs; Andrew Davidson; Thuy T T Le; Itaru Anraku; Andreas Suhrbier; Pei-Yong Shi; Alexander A Khromykh
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.